Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study

BMC Pregnancy and Childbirth

Attila Molvarec²  Ilona Kovalszky³  Júlia Schönléber²  János Rigó²  Miklós Molnár¹  Gergely Fügedi² 

[1] Institute of Pathophysiology, Semmelweis University, Budapest, Hungary;First Department of Obstetrics and Gynecology, Semmelweis University, Baross utca 27, Budapest H-1088, Hungary;First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

关键词: Pregnancy;    Preeclampsia;    Placenta;    Endocannabinoid;    Anandamide;   

Others  :  1091361
DOI  :  10.1186/s12884-014-0395-x

 received in 2014-07-12, accepted in 2014-11-18,  发布年份 2014

【 摘 要 】

Background

The endocannabinoid system plays a key role in female reproduction, including implantation, decidualization and placentation. In the present study, we aimed to analyze cannabinoid receptor 1 (CB1), CB2 and fatty acid amid hydrolase (FAAH) expressions and localization in normal and preeclamptic placenta, in order to determine whether placental endocannabinoid expression pattern differs between normal pregnancy and preeclampsia.

Methods

Eighteen preeclamptic patients and 18 normotensive, healthy pregnant women with uncomplicated pregnancies were involved in our case–control study. We determined CB1, CB2 and FAAH expressions by Western blotting and immunohistochemistry in placental samples collected directly after Cesarean section.

Results

CB1 expression semi-quantified by Western blotting was significantly higher in preeclamptic placenta, and these findings were confirmed by immunohistochemistry. CB1 immunoreactivity was markedly stronger in syncytiotrophoblasts, the mesenchymal core, decidua, villous capillary endothelial and smooth muscle cells, as well as in the amnion in preeclamptic samples compared to normal pregnancies. However, we did not find significant differences between preeclamptic and normal placenta in terms of CB2 and FAAH expressions and immunoreactivity.

Conclusions

We observed markedly higher expression of CB1 protein in preeclamptic placental tissue. Increased CB1 expression might cause abnormal decidualization and impair trophoblast invasion, thus being involved in the pathogenesis of preeclampsia. Nevertheless, we did not find significant differences between preeclamptic and normal placental tissue regarding CB2 and FAAH expressions. While the detailed pathogenesis of preeclampsia is still unclear, the endocannabinoid system could play a role in the development of the disease.

【 授权许可】

   
2014 Fügedi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Abalos E, Cuesta C, Grosso AL, Chou D, Say L: Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013, 170:1-7.
• [2]Burton GJ, Jauniaux E: Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004, 11:342-352.
• [3]Ness RB, Roberts JM: Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996, 175:1365-1370.
• [4]Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
• [5]Taylor AH, Amoako AA, Bambang K, Karasu T, Gebeh A, Lam PM, Marzcylo TH, Konje JC: Endocannabinoids and pregnancy. Clin Chim Acta 2010, 411:921-930.
• [6]Bisogno T, Ligresti A, Di Marzo V: The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav 2005, 81:224-238.
• [7]Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232:54-61.
• [8]Pacher P, Kunos G: Modulating the endocannabinoid system in human health and disease–successes and failures. FEBS J 2013, 280:1918-1943.
• [9]Fonseca BM, Correia-da-Silva G, Almada M, Costa MA, Teixeira NA: The endocannabinoid system in the postimplantation period: a role during decidualization and placentation. Int J Endocrinol 2013, 2013:510540.
• [10]Wang H, Dey SK, Maccarrone M: Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev 2006, 27:427-448.
• [11]Xie H, Sun X, Piao Y, Jegga AG, Handwerger S, Ko MS, Dey SK: Silencing or amplification of endocannabinoid signaling in blastocysts via CB1 compromises trophoblast cell migration. J Biol Chem 2012, 287:32288-32297.
• [12]El Marroun H, Tiemeier H, Steegers EA, Jaddoe VW, Hofman A, Verhulst FC, van den Brink W, Huizink AC: Intrauterine cannabis exposure affects fetal growth trajectories: the generation R study. J Am Acad Child Adolesc Psychiatry 2009, 48:1173-1181.
• [13]Hurd YL, Wang X, Anderson V, Beck O, Minkoff H, Dow-Edwards D: Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol 2005, 27:221-229.
• [14]von Dadelszen P, Magee LA, Roberts JM: Subclassification of preeclampsia. Hypertens Pregnancy 2003, 22:143-148.
• [15]Habayeb OM, Taylor AH, Bell SC, Taylor DJ, Konje JC: Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 2008, 149:5052-5060.
• [16]Park B, Gibbons HM, Mitchell MD, Glass M: Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003, 24:990-995.
• [17]Taylor AH, Finney M, Lam PM, Konje JC: Modulation of the endocannabinoid system in viable and non-viable first trimester pregnancies by pregnancy-related hormones. Reprod Biol Endocrinol 2011, 9:152. BioMed Central Full Text
• [18]Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, Mackie K, Fasano S, Colacurci N, Meccariello R, Cobellis G, Cobellis L: Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 2009, 30:516-522.
• [19]Fonseca BM, Correia-da-Silva G, Taylor AH, Lam PM, Marczylo TH, Konje JC, Teixeira NA: Characterisation of the endocannabinoid system in rat haemochorial placenta. Reprod Toxicol 2012, 34:347-356.
• [20]Sun X, Xie H, Yang J, Wang H, Bradshaw HB, Dey SK: Endocannabinoid signaling directs differentiation of trophoblast cell lineages and placentation. Proc Natl Acad Sci U S A 2010, 107:16887-16892.
• [21]Moghadam KK, Kessler CA, Schroeder JK, Buckley AR, Brar AK, Handwerger S: Cannabinoid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol 2005, 229:65-74.
• [22]Pacher P, Steffens S: The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol 2009, 31:63-77.
• [23]Randall MD, Harris D, Kendall DA, Ralevic V: Cardiovascular effects of cannabinoids. Pharmacol Therapeut 2002, 95:191-202.
• [24]Hillard CJ: Endocannabinoids and vascular function. J Pharmacol Exp Ther 2000, 294:27-32.
• [25]Aban C, Leguizamon GF, Cella M, Damiano A, Franchi AM, Farina MG: Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis. Placenta 2013, 34:67-74.